ReviewGlobal challenges (Hoboken, NJ)2025
Prevalence and Genotype Distribution of Sapovirus in China: A Systematic Review and Meta-Analysis.
Review in Global challenges (Hoboken, NJ), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prevalence and Genotype Distribution of Sapovirus in China: A Systematic Review and Meta-Analysis.Global challenges (Hoboken, NJ) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sapovirus is gaining recognition as a significant non-bacterial causative agent of acute gastroenteritis globally, contributing to both sporadic cases and outbreaks across all age groups. In China, it is identified as the second most prevalent pathogen responsible for acute gastroenteritis outbreaks, following norovirus, which underscores its public health importance. Consequently, an extensive systematic review and meta-analysis are undertaken to evaluate the prevalence and genotype distribution of sapovirus among patients presenting with acute gastroenteritis. This analysis incorporated 159 eligible studies spanning 32 provinces in China. The estimated overall prevalence of sapovirus is 1.9% (95% CI: 1.7-2.2), with an asymptomatic prevalence of 0.8% (95% CI: 0-2.5). Notably, in outbreak settings, the respective prevalence rates increase substantially to 16.4% (95% CI: 10.1-23.8) and 14.4% (95% CI: 8.9-20.7). Furthermore, these findings reveal that sapovirus GI genomes predominated in both sporadic and outbreak contexts, with genotypes GI.1, GI.2, and GII.1 being most frequently identified. These insights are crucial for enabling governments to accurately assess disease burden, inform the development of targeted vaccines, and establish evidence-based public health policies and emergency response strategies to mitigate sapovirus outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.